Compassionate use study of midostaurin in adult patients with aggressive systemic mastocytosis (ASM), mast cell leukemia (MCL) or mast cell sarcoma (MCS)

Trial Profile

Compassionate use study of midostaurin in adult patients with aggressive systemic mastocytosis (ASM), mast cell leukemia (MCL) or mast cell sarcoma (MCS)

Recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 19 Apr 2017

At a glance

  • Drugs Midostaurin (Primary)
  • Indications Acute myeloid leukaemia; Sarcoma; Systemic mastocytosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Apr 2017 Results (n=38) evaluating the impact of molecular markers (KIT D816V, S/A/Rpos) at baseline and during follow-up in midostaurin-treated advSM patients using patient data from this and NCT00782067 trial, published in the Blood
    • 09 Aug 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top